Frequently Asked Questions: Research Peptides in Europe

Research peptides are short chains of amino acids, typically between 2 and 50 amino acids in length, that are chemically synthesized for use in scientific research and laboratory experimentation. They are produced through a process called solid-phase peptide synthesis (SPPS), where amino acids are sequentially added to a growing chain anchored to a solid resin support.

After synthesis, peptides are cleaved from the resin, purified using High-Performance Liquid Chromatography (HPLC), and lyophilized (freeze-dried) into a stable powder form. This lyophilized form allows for long-term storage and easy reconstitution when needed for experiments.

Research peptides are used exclusively for in vitro studies -- laboratory experiments conducted outside a living organism. They serve as tools for investigating biological mechanisms, studying receptor interactions, and exploring cellular signaling pathways. They are not approved for human or animal consumption, clinical use, or diagnostic purposes.

Common categories of research peptides include recovery peptides (such as BPC-157 and TB-500), anti-aging peptides (such as Epithalon and GHK-Cu), and growth-related peptides (such as CJC-1295 + Ipamorelin).

Research peptides are legal to purchase and possess in most European Union member states when intended for legitimate scientific research purposes. They are classified as research chemicals rather than pharmaceuticals, controlled substances, or food supplements, which places them in a regulatory category that permits commercial sale for laboratory use.

There is no EU-wide regulation that specifically prohibits the sale or purchase of research peptides for scientific purposes. However, individual EU member states may have specific regulations or restrictions that apply. For example, some countries may require additional documentation or institutional affiliation for certain classes of compounds.

It is important to note that research peptides are not approved as medicines or therapeutic agents. They have not received marketing authorization from the European Medicines Agency (EMA) or any national medicines authority. Selling, marketing, or labeling them as medicinal products would violate EU pharmaceutical regulations. Pepspan sells all products strictly as research reagents for in vitro use only.

Researchers are responsible for verifying that their purchase and use of specific peptides complies with the laws and institutional policies applicable in their jurisdiction.

Peptides shipped within the European Union benefit from the EU single market and the free movement of goods, which means there are no customs duties, import taxes, or border inspections between EU member states. An order fast EU shipping to Spain, for example, is treated as a domestic shipment with no additional regulatory barriers.

Pepspan ships all orders from Europe using tracked courier services. Standard delivery takes 2-5 business days depending on the destination, with orders to neighboring countries (Austria, Netherlands, Belgium, France) typically arriving within 2-3 business days. Free shipping is available on all orders over EUR 100.

Lyophilized peptides are inherently stable at room temperature during the transit period, so cold chain shipping is not required. Products are packaged in discrete, unmarked outer boxes with individual vials protected by foam inserts to prevent breakage. For more details, see our Shipping Policy.

A Certificate of Analysis (COA) is a formal document produced by an independent, accredited analytical laboratory that confirms the identity, purity, and composition of a specific batch of peptide. COA verification is the process of subjecting each manufactured batch to rigorous analytical testing before it is released for sale.

A typical COA for a research peptide includes the results of two primary tests. First, High-Performance Liquid Chromatography (HPLC) measures the purity of the peptide by separating the target compound from any impurities and quantifying the relative proportions. Second, mass spectrometry (usually electrospray ionization mass spectrometry, ESI-MS) confirms the molecular weight and identity of the peptide, verifying that the correct amino acid sequence was synthesized.

COA verification is a critical quality indicator. A supplier that provides batch-specific COAs from third-party laboratories demonstrates transparency and commitment to product quality. Without a COA, there is no objective way to confirm that a product contains what it claims to contain at the stated purity level. At Pepspan, every product includes a COA from an independent laboratory.

For most research applications, a minimum purity of 95% is considered acceptable, but 98% or higher is the standard for high-quality research-grade peptides. Purity is expressed as a percentage and is determined by HPLC analysis, which measures the proportion of the target peptide relative to the total content of the sample.

Higher purity is important because impurities -- which may include truncated sequences, deletion sequences, or residual reagents from the synthesis process -- can interfere with experimental results. A peptide with 98% purity contains no more than 2% total impurities, which minimizes the risk of confounding variables in research data.

All Pepspan products meet or exceed the >98% purity threshold, verified by independent HPLC analysis documented in the Certificate of Analysis (COA) that accompanies each batch. For sensitive assays or studies where even trace impurities could affect outcomes, researchers may want to consider additional purification steps in their own laboratory.

Proper storage is essential for maintaining the stability and integrity of research peptides. Storage requirements differ depending on whether the peptide is in lyophilized (freeze-dried) form or has been reconstituted in solution.

Lyophilized peptides: Store at -20 degrees Celsius for long-term storage (years). At this temperature, lyophilized peptides remain stable with minimal degradation. For short-term storage (weeks to months), 2-8 degrees Celsius (standard refrigerator temperature) is acceptable. Lyophilized peptides should be kept in their original sealed vials, protected from light and moisture. Allow the vial to reach room temperature before opening to prevent condensation from entering the container.

Reconstituted peptides: Once dissolved in bacteriostatic water or another appropriate solvent, store at 2-8 degrees Celsius. Reconstituted peptides are less stable than their lyophilized form and should typically be used within 2-4 weeks, depending on the specific peptide. For longer storage, aliquot the reconstituted solution into single-use portions and freeze at -20 degrees Celsius to avoid repeated freeze-thaw cycles, which can degrade the peptide.

General best practices: always use clean, sterile technique when handling peptides; avoid exposure to direct sunlight or UV light; keep containers tightly sealed; and label all vials with the reconstitution date and concentration.

cGMP stands for current Good Manufacturing Practice, a comprehensive system of quality assurance standards that governs the manufacturing, processing, and packaging of pharmaceutical and research-grade products. The "current" prefix indicates that the standards are continuously updated to reflect the latest scientific knowledge, technology, and regulatory requirements.

A cGMP-certified manufacturing facility must demonstrate compliance across multiple areas: raw material testing and traceability, validated manufacturing processes, calibrated and maintained equipment, trained and qualified personnel, documented standard operating procedures (SOPs), environmental monitoring and contamination controls, comprehensive batch records, and regular internal and external audits.

For peptide manufacturing, cGMP certification ensures that each batch is produced under controlled, reproducible conditions that minimize the risk of contamination, cross-contamination, errors, and variability. This results in a product that consistently meets its stated specifications from one batch to the next.

Pepspan sources all peptides from a cGMP-certified supplier, providing an additional layer of quality assurance beyond the third-party COA testing that accompanies each batch.

Yes. Research peptides can be shipped freely across all EU internal borders without customs inspections, import duties, or additional taxes. This is a direct benefit of the European Union single market and the principle of free movement of goods established by the Treaty on the Functioning of the European Union (TFEU).

When Pepspan ships an order from Europe to any other EU member state, the shipment is treated identically to a domestic package. There are no customs declarations to file, no border delays, and no risk of a shipment being held for inspection -- the same as ordering from a domestic supplier within your own country.

For shipments to European Economic Area (EEA) countries -- Norway, Iceland, and Liechtenstein -- the process is similar, though minor customs procedures may apply at the border. Pepspan currently ships to all 27 EU member states and all 3 EEA countries.

Shipping to countries outside the EU/EEA is not currently available. For more information, see our Shipping Policy.

Research-grade and pharmaceutical-grade peptides differ primarily in their intended use, regulatory requirements, and the extent of testing they undergo.

Research-grade peptides are manufactured for use in laboratory research and scientific experimentation. They are tested for purity (via HPLC) and identity (via mass spectrometry), and are typically supplied with a Certificate of Analysis. They are not manufactured under the full regulatory oversight required for clinical products, and they are not intended for administration to humans or animals. Research-grade peptides can achieve very high purity levels (>98%), making them suitable for rigorous in vitro studies.

Pharmaceutical-grade peptides are manufactured under strict Good Manufacturing Practice (GMP) regulations and are subject to comprehensive regulatory oversight from agencies such as the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA). In addition to purity and identity testing, pharmaceutical-grade peptides undergo endotoxin testing, sterility testing, stability studies, and formulation validation. They must receive marketing authorization before they can be sold for clinical use.

The key distinction is regulatory status, not necessarily purity. A research-grade peptide at >98% purity may be analytically similar to a pharmaceutical-grade product but has not undergone the regulatory approval process required for clinical application.

Reconstituting lyophilized peptides is a straightforward process that requires careful technique to preserve the peptide's integrity. Follow these steps:

Step 1: Gather your materials. You will need the lyophilized peptide vial, bacteriostatic water (sterile water with 0.9% benzyl alcohol), an appropriately sized syringe with a needle, and alcohol swabs for sanitizing vial tops.

Step 2: Allow the peptide vial to reach room temperature if it has been stored frozen. This prevents condensation from forming inside the vial when opened.

Step 3: Sanitize the rubber stopper of both the peptide vial and the bacteriostatic water vial with an alcohol swab.

Step 4: Draw the desired volume of bacteriostatic water into the syringe. The amount depends on the desired concentration for your research protocol.

Step 5: Insert the needle through the rubber stopper of the peptide vial and slowly dispense the water down the inside wall of the vial. Do not direct the stream onto the lyophilized powder directly, as the force can damage the peptide structure.

Step 6: Allow the peptide to dissolve naturally. This may take a few minutes. If the powder does not fully dissolve, gently roll or swirl the vial between your fingers. Do not shake or vortex the vial, as vigorous agitation can denature the peptide.

Step 7: Once fully dissolved, the solution should be clear. Store at 2-8 degrees Celsius and use within the recommended timeframe (typically 2-4 weeks for most peptides).